From Science to Innovative Biopharmaceuticals in Infection, Neuroscience and Ophthalmology
Technophage, SA is a pioneering biotechnology research company dedicated to the research and development of innovative biological molecules. With a focus on infection, neuroscience, and ophthalmology, Technophage is committed to advancing healthcare through groundbreaking discoveries. Technophage, SA operates with a comprehensive strategy, managing the development of new therapeutics from the earliest stages of discovery through clinical development. This includes in-house capabilities for process development and GMP production, highlighted by the recent launch of its GMP manufacturing plant specializing in biologics such as bacteriophages and antibody fragments.
Located at Av. Professor Egas Moniz, Edifício Egas Moniz, Lisbon, 1649-028, PT, Technophage, SA is strategically positioned to foster collaborations with leading pharmaceutical companies, research centers, and universities across Europe, the USA, and Asia. The company's Lisbon headquarters, in close proximity to Santa Maria Hospital and the Instituto de Medicina Molecular João Lobo Antunes, ensures access to essential equipment and expertise necessary for developing comprehensive product solutions.
Technophage, SA is dedicated to expanding its pipeline of proprietary technologies and product offerings through active research and development programs. The company will soon provide a complete overview of its innovative work with the support of its management team. We invite the manager of Technophage, SA to create a customized and exclusive company showcase and product listing on our platform, to further enhance their commercial presence and attract new opportunities.
Compare Technophage, SA with 3 companies in Biotechnology-Research
| Comparison Field |
Technophage, SAMain Company |
1MED SAView Profile |
Qu Biologics Inc.View Profile |
Samsung BioepisView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2014 | 2007 | 2012 |
|
Company Size
|
— | 51-200 | 11-50 | 501-1,000 |
|
City
|
Agno, Canton Ticino | Burnaby, British Columbia | Yeonsu-gu, Incheon | |
|
Country
|
Canada | South Korea | ||
|
Skills & Keywords
Comparing with main company
|
16 Total Skills
Biotechnology
Biopharmaceutical
Infection therapeutics
Neuroscience research
Ophthalmology
Bacteriophage
GMP Production
bacteriophage therapeutics
screening platforms in zebrafish
ophthalmology
small domain antibodies
infection
preclinical development
neuroscience
clinical trials
biotechnology
|
7 Total
7 Unique
Unique Skills:
clinical regulatory strategy
contract research organization
Life sciences
MDR
medical device development
medical devices
+1
|
18 Total
18 Unique
Unique Skills:
arthritis
autoimmune diseases
autoimmune disorders
biologics
biotech
cancer
+12
|
11 Total
11 Unique
Unique Skills:
biopharmaceutical
biosimilars
healthcare
immunology
innovation
oncology
+5
|
Other organizations in the same industry
This company is also known as